Neurodevelopmental Disorders
Recent clinical, regulatory, research and industry developments relating to this disease.
The exposome from neurodevelopment to neurodegeneration: A narrative review.
Unraveling the Interplay Between Metabolism and Neurodevelopment in Health and Disease.
The Gut Microbiota's Role in Neurological, Psychiatric, and Neurodevelopmental Disorders.
NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models.
Obesity: exploring its connection to brain function through genetic and genomic perspectives.
The fetal programming effect of maternal immune activation (MIA) on the offspring's immune system.
Functional myelin in cognition and neurodevelopmental disorders.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity.
Research HighlightsViewHide
- 2025-10-01ResearchFilamin A in focus: unravelling the multifaceted roles of filamin A in neurodevelopment and neurological disorders.Zhang L · 2025
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Neurodevelopmental Disorders20
- Autism Spectrum Disorder6
- Brain5
- Mental Disorders4
- Nervous System Diseases3
- Attention Deficit Disorder with Hyperactivity2
- Gastrointestinal Microbiome2
- Intellectual Disability2
Leading journals6
- International journal of molecular sciences3
- Nature communications2
- Nutrients2
- Acta neuropathologica1
- BMC medicine1
- Brain : a journal of neurology1
Leading researchers8
- Zhang L2
- Abascal F1
- Abdel Rahman F1
- Abramova V1
- Adams DJ1
- Akil H1
- Akinluyi ET1
- Al Eissa M1
Affiliations (unnormalised)6
- Karolinska Institutet3
- University of Cambridge3
- Finnish Institute for Health and Welfare2
- Icahn School of Medicine at Mount Sinai2
- Université Paris Cité2
- Xiangya Hospital2
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Neurodevelopmental disorders are a group of conditions that begin during the developmental period and typically appear early in life, often before school age. They are defined by developmental deficits that impair personal, social, academic, or occupational functioning. The literature describes them as a broad class of disorders affecting brain development and function with wide clinical variability.
The literature supports a multifactorial etiology with substantial genetic contribution. Reported contributors include gene vulnerability, mutational load, and a two-hit model, and maternal nutritional inadequacy during pregnancy has also been associated with adverse neurodevelopmental outcomes. The supplied grounding also links neurodevelopmental disorders to microbiota-related and circadian influences, but does not support a single unified cause.
Multiple converging biological pathways are implicated, including synaptic plasticity and function, chromatin remodeling, and the mTOR pathway. Other grounded mechanisms include glutamate-mediated excitotoxicity, altered myelin function, and microbiota-gut-brain axis effects through immune, neuronal, and endocrine/systemic pathways. The literature also notes associations with neuronal plasticity and N-methyl-D-aspartate receptor-related signaling.
Genetic vulnerability and higher mutational burden are supported risk factors. Maternal undernutrition and inadequate intake of specific nutrients during pregnancy are also associated with neurodevelopmental impairment. Circadian disruption is described as increasing the risk for neurologic and psychiatric disorders, but the grounding does not establish it specifically as a risk factor for all neurodevelopmental disorders.
The supplied grounding does not provide a specific standard treatment for neurodevelopmental disorders. It indicates that mechanistic understanding may identify candidates for treatment approaches, but no established modality or drug-class standard is described. Accordingly, treatment cannot be summarized from the provided material.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.